A Phase II/III study comparing carboplatin and irinotecan with carboplatin and etoposide for the treatment of elderly patients with extensive-disease small-cell lung cancer (JCOG1201)

2014 ◽  
Vol 45 (1) ◽  
pp. 115-118 ◽  
Author(s):  
J. Eba ◽  
T. Shimokawa ◽  
K. Nakamura ◽  
T. Shibata ◽  
Y. Misumi ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Elderly Patients ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Extensive Disease

scholarly journals P1-215: Three drug regiment (Irinotecan, Carboplatin and Etoposide) as a front line treatment in extensive disease small-cell lung cancer: phase II trial

2007 ◽  
Vol 2 (8) ◽  
pp. S824
Author(s):  
Andriani G. Charpidou ◽  
Nikolaos Katirtzoglou ◽  
Ioannis Gkiozos ◽  
Eleni Karapanagiotou ◽  
Anna Rigopoulou ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Line Treatment ◽  
Front Line ◽  
Small Cell Lung ◽  
Extensive Disease

scholarly journals P3-076: Phase II study of docetaxel and cisplatin in elderly patients with advanced non-small cell lung cancer

2007 ◽  
Vol 2 (8) ◽  
pp. S710
Author(s):  
Qamruzzaman Chowdhury ◽  
Faruqui Mesbary ◽  
Begum F. Ara ◽  
Aziz Shahnoor ◽  
Hasan Mohibul
Keyword(s):  
Lung Cancer ◽  
Elderly Patients ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Small Cell ◽  
Small Cell Lung

A phase II study of weekly paclitaxel combined with carboplatin for elderly patients with advanced non-small cell lung cancer

Lung Cancer ◽  
2006 ◽  
Vol 52 (1) ◽  
pp. 83-87 ◽  
Author(s):  
Akira Inoue ◽  
Kazuhiro Usui ◽  
Osamu Ishimoto ◽  
Nobuyuki Matsubara ◽  
Masashi Tanaka ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Elderly Patients ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Small Cell ◽  
Weekly Paclitaxel ◽  
Small Cell Lung
Sign in / Sign up

Export Citation Format

Share Document